MicroRNA profiling in predictive oncology of colorectal cancer.

Autoři

SVOBODA Marek SLABÝ Ondřej HÉŽOVÁ Renata FABIAN Pavel KOCÁKOVÁ Ilona ONDROVÁ Barbora VYZULA Rostislav

Rok publikování 2010
Druh Konferenční abstrakty
Citace
Popis Fluoropyrimidine-base chemoradiotherapy before total mesorectal excision (TME) is currently the gold standard treatment for stage II and III rectal cancer patients. Pathological complete response is related with a longer relaps and overall survival. On the other hand, patients with a primary resistant tumors could be spared exposure to chemotherapy and radiation that are associated with substantial adverse effects and costs, and surgery could be schduled without delay. We have used microRNA profilling to identify in our series responders and non responders to preoperative treatment.

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.

Další info